Skip to content

Merck & Co., Inc.

MRK· NYSECore metricsCIK 310158

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.17%
Market cap
$362.27B
2.47B shares
Filings
1,075
$18.09B
Q3 2026+1.3% FY25 yoy
$5.07B
Q3 2026+6.6% FY25 yoy
—
—
—
$12.92B
Q3 2026derived−31.7% FY25 yoy
$2.04
Q3 2026+8.0% FY25 yoy
$9.55B
Q3 2026+10.0% FY25 yoy
$362.27B
147.7×
5.4×
8.1×
4.07%
2.31%

Twelve months to Sep 30, 2026 · derived

Price

$146.95+61.57%+$56.00past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$65.01BFY 2025
$65.01B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$65,011,000,000reported
FY 20242024-12-31$64,168,000,000reported
FY 20232023-12-31$60,115,000,000reported
FY 20222022-12-31$59,283,000,000reported
FY 20212021-12-31$48,704,000,000reported
FY 20202020-12-31$41,518,000,000 revisedreported
FY 20192019-12-31$39,121,000,000 revisedreported
FY 20182018-12-31$42,294,000,000reported
FY 20172017-12-31$40,122,000,000reported
FY 20162016-12-31$39,807,000,000reported
FY 20152015-12-31$39,498,000,000reported
FY 20142014-12-31$42,237,000,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$8.18B$5.08B$13.26B$3.282.47B sh−2.1%107.3%
FY2024$7.84B$1.31B$9.15B$3.122.53B sh−0.3%50.5%
FY2023$7.45B$1.35B$8.79B$2.962.53B sh−0.2%96.2%
FY2022$7.01B$0.00$7.01B$2.802.54B sh+0.4%47.7%
FY2021$6.61B$840.00M$7.45B$2.642.53B sh−0.1%85.9%

Segments

Revenue by Segments, FY2018 to FY2025FY2018Pharmaceutical segment · FY2018 · $37.69BAnimal Health · FY2018 · $4.21BOther segments · FY2018 · $250.00MFY2019Pharmaceutical segment · FY2019 · $34.10BAnimal Health · FY2019 · $4.39BOther segments · FY2019 · $175.00MFY2020Pharmaceutical segment · FY2020 · $36.61BAnimal Health · FY2020 · $4.70BOther segments · FY2020 · $23.00MFY2021Pharmaceutical segment · FY2021 · $42.75BAnimal Health · FY2021 · $5.57BFY2022Pharmaceutical segment · FY2022 · $52.01BAnimal Health · FY2022 · $5.55BFY2023Pharmaceutical segment · FY2023 · $53.58BAnimal Health · FY2023 · $5.63BFY2024Pharmaceutical segment · FY2024 · $57.40BAnimal Health · FY2024 · $5.88BFY2025Pharmaceutical segment · FY2025 · $58.14BAnimal Health · FY2025 · $6.35B
LineFY2025ShareChange
Pharmaceutical segment$58.14B89%+1.3%
Animal Health$6.35B9.8%+8.1%
Other segments———
Total$65.01B

From the 10-K filed Feb 24, 2026MRK

Pharmaceutical preparations

Merck & Co., Inc. is the 3rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Merck & Co., Inc. · CIK 310158 · Engraved from SEC EDGAR